Innovative Therapies for Migraine Prevention

This chapter examines a new monoclonal antibody therapy targeting PACAP for migraine prevention, comparing it with existing CGRP inhibitors. It highlights the need for further clinical trials to evaluate the efficacy of this dual therapy and the ongoing commitment of researchers to advance migraine treatment options.